Aravive Announces Preliminary Data From Phase 1b Trial Evaluating Batiraxcept In Combination With Cabozantinib In Clear Cell Renal Cell Carcinoma To Be Presented At 2021 Society For Immunotherapy Of Cancer Annual Meeting